247 related articles for article (PubMed ID: 32687852)
41. Immunosuppression in hematological cancer patients with Covid-19 -Uncomplicated infections but delayed viral clearance?
Boyd K; Parcell B; Tauro S
Leuk Res; 2020 Sep; 96():106407. PubMed ID: 32652329
[No Abstract] [Full Text] [Related]
42. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
Greco A; Buccheri S; D'Arrigo P; Calderone D; Agnello F; Monte M; Milluzzo RP; Franchina AG; Ingala S; Capodanno D
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):335-337. PubMed ID: 32671399
[No Abstract] [Full Text] [Related]
43. Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Li G; De Clercq E
Nat Rev Drug Discov; 2020 Mar; 19(3):149-150. PubMed ID: 32127666
[No Abstract] [Full Text] [Related]
44. Related molecular mechanisms of COVID-19, hypertension, and diabetes.
Akkus E; Sahin M
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E881. PubMed ID: 32479159
[No Abstract] [Full Text] [Related]
45. Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
Marouf BH; Dizaye K
Drug Discov Ther; 2020; 14(3):109-116. PubMed ID: 32669519
[TBL] [Abstract][Full Text] [Related]
46. Kidney Transplantation and COVID-19.
Merhi B; Gohh R
R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010
[No Abstract] [Full Text] [Related]
47. It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.
Kay AW; Ness TE; Martinez L; Mandalakas AM
Am J Trop Med Hyg; 2020 Oct; 103(4):1348-1349. PubMed ID: 32876009
[No Abstract] [Full Text] [Related]
48. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
Gonzales-Zamora JA; Quiroz T; Vega AD
Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623
[TBL] [Abstract][Full Text] [Related]
49. Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.
Shirazi FM; Banerji S; Nakhaee S; Mehrpour O
Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):2001-2002. PubMed ID: 32557325
[No Abstract] [Full Text] [Related]
50. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Carradori S
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
[No Abstract] [Full Text] [Related]
51. Understanding of COVID-19 based on current evidence.
Sun P; Lu X; Xu C; Sun W; Pan B
J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
[TBL] [Abstract][Full Text] [Related]
52. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.
Ryan PM; Caplice N
Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532804
[No Abstract] [Full Text] [Related]
53. [Remdesivir for patients with COVID-19].
Augustin M; Hallek M; Nitschmann S
Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516
[No Abstract] [Full Text] [Related]
54. Emerging pharmacotherapy for COVID-19.
Lipworth B; Kuo CR; Chan R
J R Coll Physicians Edinb; 2020 Jun; 50(2):133-137. PubMed ID: 32568282
[TBL] [Abstract][Full Text] [Related]
55. Is the type of diabetes treatment relevant to outcome of COVID-19?
Bloomgarden Z
J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
[No Abstract] [Full Text] [Related]
56. Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
Li C; Wang L; Ren L
Virus Res; 2020 Sep; 286():198073. PubMed ID: 32592817
[TBL] [Abstract][Full Text] [Related]
57. Considerations for Statin Therapy in Patients with COVID-19.
Dashti-Khavidaki S; Khalili H
Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
[No Abstract] [Full Text] [Related]
58. Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza.
Anderson PO
Breastfeed Med; 2020 Mar; 15(3):128. PubMed ID: 32129667
[No Abstract] [Full Text] [Related]
59. Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
Alonso DF; Farina HG
Int J Antimicrob Agents; 2020 Sep; 56(3):106125. PubMed ID: 32739476
[No Abstract] [Full Text] [Related]
60. Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
Oldenburg CE; Doan T
Am J Trop Med Hyg; 2020 Jun; 102(6):1154-1155. PubMed ID: 32297590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
